Annual Total Debt:
$510.55M+$395.38M(+343.30%)Summary
- As of today (May 29, 2025), ARWR annual total debt is $510.55 million, with the most recent change of +$395.38 million (+343.30%) on September 30, 2024.
- During the last 3 years, ARWR annual total debt has risen by +$485.01 million (+1898.64%).
- ARWR annual total debt is now at all-time high.
Performance
ARWR Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$388.24M-$137.03M(-26.09%)Summary
- As of today (May 29, 2025), ARWR quarterly total debt is $388.24 million, with the most recent change of -$137.03 million (-26.09%) on March 31, 2025.
- Over the past year, ARWR quarterly total debt has increased by +$269.32 million (+226.48%).
- ARWR quarterly total debt is now -26.09% below its all-time high of $525.27 million, reached on December 31, 2024.
Performance
ARWR Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
ARWR Total debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +343.3% | +226.5% |
| 3 y3 years | +1898.6% | +1416.1% |
| 5 y5 years | +100.0% | +2511.4% |
ARWR Total debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1898.6% | -26.1% | +1416.1% |
| 5 y | 5-year | at high | >+9999.0% | -26.1% | +2511.4% |
| alltime | all time | at high | >+9999.0% | -26.1% | >+9999.0% |
ARWR Total debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $388.24M(-26.1%) |
| Dec 2024 | - | $525.27M(+2.9%) |
| Sep 2024 | $510.55M(+343.3%) | $510.55M(+332.3%) |
| Jun 2024 | - | $118.09M(-0.7%) |
| Mar 2024 | - | $118.92M(+0.3%) |
| Dec 2023 | - | $118.58M(+3.0%) |
| Sep 2023 | $115.17M(+41.2%) | $115.17M(+39.2%) |
| Jun 2023 | - | $82.73M(-0.1%) |
| Mar 2023 | - | $82.78M(+0.8%) |
| Dec 2022 | - | $82.13M(+0.7%) |
| Sep 2022 | $81.58M(+219.3%) | $81.58M(+0.6%) |
| Jun 2022 | - | $81.11M(+216.8%) |
| Mar 2022 | - | $25.61M(+1.2%) |
| Dec 2021 | - | $25.32M(-0.9%) |
| Sep 2021 | $25.55M(+20.8%) | $25.55M(+5.8%) |
| Jun 2021 | - | $24.14M(+1.4%) |
| Mar 2021 | - | $23.80M(+14.1%) |
| Dec 2020 | - | $20.87M(-1.3%) |
| Sep 2020 | $21.14M(>+9900.0%) | $21.14M(-1.1%) |
| Jun 2020 | - | $21.37M(+43.8%) |
| Mar 2020 | - | $14.87M(+0.2%) |
| Dec 2019 | - | $14.84M(>+9900.0%) |
| Sep 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(-100.0%) |
| Sep 2018 | $2.33M(-8.2%) | $2.33M(-2.2%) |
| Jun 2018 | - | $2.38M(-2.2%) |
| Mar 2018 | - | $2.43M(-2.1%) |
| Dec 2017 | - | $2.48M(-2.0%) |
| Sep 2017 | $2.53M(-7.1%) | $2.53M(-1.9%) |
| Jun 2017 | - | $2.58M(-1.9%) |
| Mar 2017 | - | $2.63M(-1.8%) |
| Dec 2016 | - | $2.68M(-1.7%) |
| Sep 2016 | $2.73M(+259.7%) | $2.73M(-17.9%) |
| Jun 2016 | - | $3.32M(+411.3%) |
| Mar 2016 | - | $650.00K(-7.7%) |
| Dec 2015 | - | $704.20K(-7.1%) |
| Sep 2015 | $758.30K(-25.8%) | $758.30K(-6.6%) |
| Jun 2015 | - | $812.20K(-6.2%) |
| Mar 2015 | - | $865.80K(-5.8%) |
| Dec 2014 | - | $919.20K(-10.1%) |
| Sep 2014 | $1.02M(-55.6%) | $1.02M(-4.9%) |
| Jun 2014 | - | $1.08M(-49.5%) |
| Mar 2014 | - | $2.13M(-6.6%) |
| Dec 2013 | - | $2.28M(-1.1%) |
| Sep 2013 | $2.30M(-5.4%) | $2.30M(-0.4%) |
| Jun 2013 | - | $2.31M(-0.4%) |
| Mar 2013 | - | $2.32M(-4.5%) |
| Dec 2012 | - | $2.43M(-0.3%) |
| Sep 2012 | $2.44M | $2.44M(+4.0%) |
| Jun 2012 | - | $2.34M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $2.35M(-0.3%) |
| Dec 2011 | - | $2.36M(+288.4%) |
| Sep 2011 | $606.80K(+21.4%) | $606.80K(+8.2%) |
| Jun 2011 | - | $560.90K(+7.9%) |
| Mar 2011 | - | $519.70K(+3.9%) |
| Dec 2010 | - | $500.00K(0.0%) |
| Sep 2010 | $500.00K(-59.2%) | $500.00K(-13.0%) |
| Jun 2010 | - | $574.80K(-27.8%) |
| Mar 2010 | - | $796.40K(-21.4%) |
| Dec 2009 | - | $1.01M(-17.4%) |
| Sep 2009 | $1.23M(-20.2%) | $1.23M(-14.5%) |
| Jun 2009 | - | $1.44M(-60.7%) |
| Mar 2009 | - | $3.66M(-5.2%) |
| Dec 2008 | - | $3.86M(+150.9%) |
| Sep 2008 | $1.54M(>+9900.0%) | $1.54M(>+9900.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sep 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) |
| Sep 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sep 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2003 | - | $629.50K(-0.2%) |
| Mar 2003 | - | $630.50K(-0.2%) |
| Dec 2002 | - | $632.00K(-0.2%) |
| Sep 2002 | $633.50K(+13.3%) | $633.50K(-0.2%) |
| Jun 2002 | - | $635.00K(+18.4%) |
| Mar 2002 | - | $536.50K(-3.9%) |
| Dec 2001 | - | $558.00K(-0.2%) |
| Sep 2001 | $559.00K(-0.7%) | $559.00K(-0.3%) |
| Jun 2001 | - | $560.50K(-0.3%) |
| Mar 2001 | - | $562.00K(-0.1%) |
| Dec 2000 | - | $562.50K(-0.1%) |
| Sep 2000 | $563.00K(-0.4%) | $563.00K(-0.1%) |
| Jun 2000 | - | $563.50K(-0.1%) |
| Mar 2000 | - | $564.00K(-0.1%) |
| Dec 1999 | - | $564.50K |
| Sep 1999 | $565.00K(-47.2%) | - |
| Sep 1998 | $1.07M(+4.5%) | - |
| Sep 1997 | $1.02M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total debt year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total debt year-on-year change?
What is Arrowhead Pharmaceuticals annual total debt?
The current annual total debt of ARWR is $510.55M
What is the all time high annual total debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total debt is $510.55M
What is Arrowhead Pharmaceuticals annual total debt year-on-year change?
Over the past year, ARWR annual total debt has changed by +$395.38M (+343.30%)
What is Arrowhead Pharmaceuticals quarterly total debt?
The current quarterly total debt of ARWR is $388.24M
What is the all time high quarterly total debt for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total debt is $525.27M
What is Arrowhead Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ARWR quarterly total debt has changed by +$269.32M (+226.48%)